Creative Medical Technology Holdings, Inc. financial data

Symbol
CELZ on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
211 E. Osborn Rd., Phoenix, AZ
State of incorporation
NV
Fiscal year end
December 31
Former names
JOLLEY MARKETING INC (to 5/13/2016)
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.51K % +63.8%
Quick Ratio 1.56 % +52.6%
Debt-to-equity 3.97 %
Return On Assets -56.1 % -6.57%
Operating Margin -35.7K % -173%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.34M shares -6.46%
Common Stock, Shares, Outstanding 1.34M shares -6.5%
Entity Public Float 6.63M USD +7.1%
Common Stock, Value, Issued 1.43K USD 0%
Weighted Average Number of Shares Outstanding, Basic 10.9M shares +320%
Weighted Average Number of Shares Outstanding, Diluted 14.1M shares +474%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 17K USD -76.9%
Cost of Revenue 6.8K USD -68.7%
Research and Development Expense 2.69M USD -54.1%
Operating Income (Loss) -6.06M USD +36.9%
Nonoperating Income (Expense) 332K USD +31.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.73M USD +38.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -5.73M USD +38.7%
Earnings Per Share, Basic -0.93 USD/shares -113%
Earnings Per Share, Diluted -0.93 USD/shares -117%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.51M USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 3.39K USD -66.7%
Assets, Current 7.6M USD -44.6%
Other Assets, Noncurrent 3.28K USD
Assets 7.99M USD -43.4%
Accounts Payable, Current 322K USD -6.46%
Accrued Liabilities, Current 39.9K USD 0%
Liabilities, Current 376K USD -5.58%
Liabilities 376K USD -5.58%
Retained Earnings (Accumulated Deficit) -61.7M USD -10.2%
Stockholders' Equity Attributable to Parent 7.61M USD -44.5%
Liabilities and Equity 7.99M USD -43.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -897K USD +76.7%
Net Cash Provided by (Used in) Financing Activities -82.8K USD
Net Cash Provided by (Used in) Investing Activities 6.52M USD +29.4%
Common Stock, Shares Authorized 5M shares 0%
Common Stock, Shares, Issued 1.43M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.47M USD +87.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 6.27M USD +29.4%
Deferred Tax Assets, Operating Loss Carryforwards 6.27M USD +29.4%
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 69.7M USD +0.05%
Amortization of Intangible Assets 107K USD +16.3%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 9.16K USD 0%
Interest Expense 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares